Navigation Links
Tiny sacs released by brain tumor cells carry information that may guide treatment
Date:11/16/2008

Microvesicles tiny membrane-covered sacs released from glioblastoma cells contain molecules that may provide data that can guide treatment of the deadly brain tumor. In their report in the December 2008 Nature Cell Biology, which is receiving early online release, Massachusetts General Hospital (MGH) researchers describe finding tumor-associated RNA and proteins in membrane microvesicles called exosomes in blood samples from glioblastoma patients. Detailed analysis of exosome contents identified factors that could facilitate a tumor's growth through delivery of genetic information or proteins, or signify its vulnerability to particular medications.

"Glioblastomas release exosomes in sufficient quantities to pass the blood-brain barrier. We were able to isolate them, analyze the RNA transcripts and show how they might be used as biomarkers to guide targeted therapy and monitor treatment response," says Johan Skog, PhD, the study's lead author, who works in the laboratory of Xandra Breakefield, PhD, at the MGH Neuroscience Center. "Exosomes also may someday be used to deliver therapeutic molecules to the site of a tumor," he added.

Many types of cells release exosomes as part of normal cell-to-cell communication, and several types of tumors are known to shed exosomes containing proteins that can alter the cellular environment to favor tumor growth. The current investigation is believed to be the first to carefully analyze the contents of exosomes shed from glioblastoma cells and characterize their contents.

The investigators first analyzed tumor cells from three glioblastomas and verified that the cells released exosomes containing RNA and protein molecules. Some messenger RNAs related to activities such as cell proliferation and migration, angiogenesis, and immune response were highly abundant in the exosomes. When glioblastoma exosomes were cultured with normal cells, tumor RNA was delivered into the normal cells a
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Bryant College Football Coach of the Year Watch List Released
2. T-Gone Tinnitus Cures -- A Potent New Tinnitus Formula Released
3. State Support for Programs to Decrease Tobacco Use Among Teens and Adults on the Decline According to Trend Report Released Today
4. New Web-Based Compliance Program Released by RiskWatch
5. Authoritative Report on Physician Perspectives Released Today
6. Diabetes Online Health Guide Released on NHS Choices
7. Online NHS Health Guides for Long-Term Conditions Released on NHS Choices
8. Womens Health Guide Aged 18-39 Released on NHS Choices
9. Hope, Volume One, a CD benefiting Suicide Awareness Voices of Education (SAVE), to Be released on June 24, 2008
10. Authoritative Report on Emergency Department Experiences Released Today
11. Worlds Leading Health Experts Urge Countries to Use Newly Released Data to Prevent the Death of Millions of Children Due to Rotavirus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...YERS, Fla., July 2 Acet...counter and prescription medicines to help relieve...aminophen by a brand name, Tylenol and prescriptio...visory committee for the FDA met on June 30, 2009 ...f acetaminophen. The committee voted 20-17 to urg...
(Date:7/2/2009)...Health one of 63 businesses honored in Washington,...-USNewswire/ -- Texas Health Resources has recei...ard from the National Business Group on Health. ,.../20090702/DC41773LOGO ) , , The award recogn...ive programs that promote a healthy workplace and ...
(Date:7/2/2009)...ores weight problems faced by youngsters with the ...News) -- Children with type 1 diabetes are more li...se, increasing their risk of serious health compli... a major study that explored the weight problems f...ss common form of the disease that usually shows u...
(Date:7/2/2009)...statistical and biological issues need to be addre...for early detection of cancer, according to a comm...the National Cancer Institute . , The biomarker ...tests includes the identification of promising bio...d definitive evaluation of biomarkers for cancer s...
Breaking Medicine News(10 mins):Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3Health News:Kids With Type 1 Diabetes Often Overweight 2
...g syndrome is a disorder of neurological origin. T.../ legs becomes strong even if the person is statio...er from sensations like burning or itching, or eve... These sensations are termed as paresthesias or dy...
...of University of Southern California, US had been ...asthma and smoking habit of mother and maternal gr... of families with children suffering from asthma r...her before, during and after the pregnancy. The hi...
...d Drug Administration (FDA) of US had warned the p...ertain drugs broadly called as atypical antipsycho...rugs, aripiprazole, olanzapine, quetiapine, risper...approved for the clinical treatment of schizophren...
... of a study on dietary minerals and their effects ...he diets of children may help them in increasing t...on the diets of Chinese children of age between 6 ...supplement of 20mg of zinc alone and the other gro...
Other Medicine News:
(Date:7/2/2009)...July 2 Acura Pharmaceuti...als, Inc. (NYSE: KG ) announced today that the U...a Complete Response Letter regarding the New Drug ...nd niacin, USP) Tablets CII, an immediate release ...ere pain. , , (Logo: http://www.newscom.co...
(Date:6/30/2009)...re/ -- If you have been eating Garlic to keep the ...e there is absolutely no scientific evidence that ...ying garlic has plenty of evidence to prove it kee...rassy lawns is not as strange as it seems. Mosquit...c. is being used successfully by city parks, golf ...
(Date:6/30/2009)...Calixa Therapeutics Inc. today announced the initi...tients with complicated urinary tract infections. ...losporin antibiotic with excellent in vitro and ... , including drug resistant isolates. Calixa is i...serious bacterial infections in hospitalized patie...
(Date:6/29/2009)...tients achieved primary and secondary endpoints ,... AcelRx Pharmaceuticals, Inc. today announced posi...y evaluating the safety and efficacy of its ARX-01...te post-operative pain in patients requiring opioi...acebo, patients receiving ARX-01 Sufentanil NanoTa...
Breaking Medicine Technology:Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 3Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Pinstripe Healthcare Group Adds Veteran HR Executive Warner as Client Services Director 13088 1Pinstripe Healthcare Group Adds Veteran HR Executive Warner as Client Services Director 13088 2Exelixis Announces March 4 Webcast of Presentation at the Susquehanna SIGnificant Options in Healthcare Conference 3616 1China Medical Technologies Reports Third Quarter Financial Results 13079 1China Medical Technologies Reports Third Quarter Financial Results 13079 2China Medical Technologies Reports Third Quarter Financial Results 13079 3China Medical Technologies Reports Third Quarter Financial Results 13079 4China Medical Technologies Reports Third Quarter Financial Results 13079 5China Medical Technologies Reports Third Quarter Financial Results 13079 6China Medical Technologies Reports Third Quarter Financial Results 13079 7China Medical Technologies Reports Third Quarter Financial Results 13079 8China Medical Technologies Reports Third Quarter Financial Results 13079 9China Medical Technologies Reports Third Quarter Financial Results 13079 10China Medical Technologies Reports Third Quarter Financial Results 13079 11China Medical Technologies Reports Third Quarter Financial Results 13079 12As Healthcare Spending is Predicted to Exceed 4 Trillion in Less Than 10 Years Technology will be Called upon to Stem the Tide 13074 1As Healthcare Spending is Predicted to Exceed 4 Trillion in Less Than 10 Years Technology will be Called upon to Stem the Tide 13074 2
...provide a new therapeutic approach for the treatme...ITY, April 17, 2007 /PRNewswire-FirstCall/ - AEter...utical company,focused on endocrine therapy and on...ivo data for its growth hormone-releasing,hormone ... American,Association for Cancer Research (AACR) A...
...y announced, primary endpoint not met; plausibly,c...ent with ERBITUX,-, NEW YORK, April 16, 2007 /PRNe...and Bristol-Myers Squibb Company today,announced d...,open-label, multi-center Phase III trial - compa...notecan alone in patients with,metastatic colorect...
Other Medicine Technology:AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
The Premier Anterior Cervical Plate System allows for axial load sharing bone screw translation along slots in the plate, while maintaining constrained fixation at the distal end of the construct. In
Cervive is an Anterior Cervical Plating System that has been engineered to provide flexibility and simplicity for the spinal surgeon, allowing replication of normal anatomical function and safe fixat
...compression plate acc. to Matzen is used for the a...with the exception of C0-C2. The implant provides ...the bone transplant has consolidated. The plate is...ible along the center line. It has instrument repo...
The Codman anterior cervical plate is designed for immediate internal fixation of the cervical spine following bone grafting procedures.
Medicine Products: